✦ LIBER ✦

Anti-TNF Therapy Improves Stored Body Iron Serum Markers in Inflammatory Bowel Disease Patients

✍ Scribed by Pastorelli, Luca ;Testa, Cristian ;Rigolini, Roberta ;Giubbilini, Paola ;Spina, Luisa ;Tontini, Gianeugenio ;Munizio, Nadia ;De Salvo, Carlo ;Rampoldi, Benedetta ;Costa, Elena ;Vecchi, Maurizio

Book ID: 122246080
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 104 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)61114-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.259: INFLIXIMAB IMPROVES STORED BODY

P.1.259: INFLIXIMAB IMPROVES STORED BODY IRON SERUM MARKERS IN INFLAMMATORY BOWEL DISEASE PATIENTS

✍ L. Pastorelli; C. Testa; R. Rigolini; P. Giubbilini; L. Spina; G. Tontini; N. Mu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Cytomegalovirus infection in inflammator

Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy

✍ Valeria D’Ovidio; Piero Vernia; Giuseppe Gentile; Angela Capobianchi; Adriana Ma 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 123 KB

P099 Anti-TNF-alpha treatment improves c

P099 Anti-TNF-alpha treatment improves carbohydrate metabolism in patients with inflammatory bowel disease

✍ Lorinczy, K.; Miheller, P.; Patócs, A.; Székely, H.; Reismann, P.; Csontos, Á.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 105 KB

Mo1174 Lipid Profile in Inflammatory Bow

Mo1174 Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy

✍ Miranda-Bautista, Jose; de Gracia, Celia; López-Ibáñez, María; Barrientos, María 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 357 KB

P448 Inflammatory and cancerous skin les

P448 Inflammatory and cancerous skin lesions in inflammatory bowel disease patients treated with anti-TNF therapy

✍ Ocepek, A.; Pernat Drobez, C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 155 KB

Tuberculous chemoprophylaxis requirement

Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy

✍ Yamile Zabana; Eugeni Domènech; Antonio López San Román; Belén Beltrán; José Lui 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Background: Preventive actions are advised since the use of anti-tumor necrosis factor (TNF) agents is known to increase the risk of tuberculosis (TB). No data related to the effectiveness and safety of the preventive chemoprophylaxis (ChP) for TB in inflammatory bowel disease (IBD) patients are ava